The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Jorge Castillo | EHA 2018 | Overview of the safety and efficacy of venetoclax in patients with WM

Jun 18, 2018

23rd Congress of European Hematology Association, 14-17 June 2018, Stockholm, Sweden
Jorge Castillo
Dana-Farber Cancer Institute, Boston, US

Interview topic: Overview of the safety and efficacy of venetoclax in patients with WM

Jorge Castillo | EHA 2018 | Overview of the safety and efficacy of venetoclax in patients with WM